Neuromeka Co (348340.KQ) Stock Price
Neuromeka Co Price
Over the last 6 years Neuromeka Co grew revenue by 17.5% annually, reaching 18.95 B KRW. For Neuromeka Co, the net margin of -115.9% is down versus -89.7% a few years ago. The consensus 12-month price target for Neuromeka Co is 31,620.00 KRW, about 127.6% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
Neuromeka Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Neuromeka Co business model & stock analysis
Frequently asked questions about Neuromeka Co
Analysts currently set an average price target of 31,620.00 KRW for the Neuromeka Co stock (median: 31,620.00 KRW), implying +122.7 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the Neuromeka Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Neuromeka Co to generate revenue of 40.00 B KRW and earnings per share of 34.36 KRW.
Converted at the current exchange rate, the Neuromeka Co share trades at 9.41 EUR (13,890.00 KRW).
The expected revenue of Neuromeka Co is 40.00 B KRW. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Neuromeka Co is 711.42 M KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Neuromeka Co is currently 404.28. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Neuromeka Co stock.
The price-to-sales ratio (P/S) of Neuromeka Co is currently 7.19. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Neuromeka Co stock.
The Eulerpool Quality Score for Neuromeka Co is 3/10.
The ISIN of Neuromeka Co is KR7348340001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Neuromeka Co is 348340.KQ. The ticker symbol is used to trade Neuromeka Co shares on the stock exchange.
Neuromeka Co stock
Neuromeka Co Peer Group
Neuromeka Co FIGI
All fundamentals and in-depth analysis of Neuromeka Co
Our stock analysis for Neuromeka Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neuromeka Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.